PharmaShots | Incisive News in 3 Shots

Subscribe Now

teva pharmaceuticals

Teva Reports Results from the P-III Study of Ajovy (fremanezumab) to Prevent Migraine in Chinese Patients

Teva Reports Results from the P-III Study of Ajovy (fremanezumab) to Prevent Migraine in Chinese Patients

April 12, 2024

PharmaShots Weekly Snapshots (April 01 – April 05, 2024)

PharmaShots Weekly Snapshots (April 01 – April 05, 2024)

April 5, 2024

Teva Pharmaceuticals and mAbxience Join Hands to Develop Biosimilar Candidates for Treating Oncology Indications

Teva Pharmaceuticals and mAbxience Join Hands to Develop Biosimilar Candidates for Treating Oncology Indications

April 5, 2024

Teva Pharmaceuticals Reports the Results of Uzedy in P-III Trial as an Extended-Release Injectable Suspension for Schizophrenia

Teva Pharmaceuticals Reports the Results of Uzedy in P-III Trial as an Extended-Release Injectable Suspension for Schizophrenia

November 2, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us